Warning: The NCBI web site requires JavaScript to function. more...
Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005-2006 in Palermo, Italy.
Di Carlo P, Romano A, Salsa L, Gueli A, Poma A, Fucà F, Dones P, Collura M, Pampinella D, Motisi D, Corsello G.
Ital J Pediatr. 2009 May 2;35(1):11.
Related citations
Incidence of respiratory syncytial virus infection in infants and young children referred to the emergency departments for lower respiratory tract diseases in Italy.
Medici MC, Arcangeletti MC, Merolla R, Chezzi C; Osservatorio VRS Study Group.
Acta Biomed. 2004 Apr;75(1):26-33.
Respiratory syncytial virus infection in a Sicilian pediatric population: risk factors, epidemiology, and severity.
Corsello G, Di Carlo P, Salsa L, Gabriele B, Meli L, Bruno S, Titone L.
Allergy Asthma Proc. 2008 Mar-Apr;29(2):205-10.
Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
Lanari M, Giovannini M, Giuffré L, Marini A, Rondini G, Rossi GA, Merolla R, Zuccotti GV, Salvioli GP; Investigators R.A.DA.R. Study Group.
Pediatr Pulmonol. 2002 Jun;33(6):458-65.
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
Nokes DJ, Okiro EA, Ngama M, Ochola R, White LJ, Scott PD, English M, Cane PA, Medley GF.
Clin Infect Dis. 2008 Jan 1;46(1):50-7.
[Lower respiratory tract infections with influenza and respiratory syncytial viruses in hospitalized elderly patients during the 2005-2006 winter season].
Haber N, Dekimeche S, Cantet C, Marquand D, Szekely C, Lebon P.
Presse Med. 2009 Jun;38(6):893-903. Epub 2008 Dec 18. French.
Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR, Simoes EA, Hemming VG.
Pediatrics. 1995 Apr;95(4):463-7.
The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years.
Resch B, Gusenleitner W, Müller W.
Infection. 2002 Aug;30(4):193-7.
Clinical and epidemiologic characteristics of viral infections in a neonatal intensive care unit during a 12-year period.
Verboon-Maciolek MA, Krediet TG, Gerards LJ, Fleer A, van Loon TM.
Pediatr Infect Dis J. 2005 Oct;24(10):901-4.
Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
Madhi SA, Kuwanda L, Cutland C, Klugman KP.
J Clin Virol. 2006 Jul;36(3):215-21. Epub 2006 May 5.
Respiratory syncytial virus associated illness in high-risk children and national characterisation of the circulating virus genotype in South Africa.
Madhi SA, Venter M, Alexandra R, Lewis H, Kara Y, Karshagen WF, Greef M, Lassen C.
J Clin Virol. 2003 Jul;27(2):180-9.
Incidence of respiratory syncytial virus positivity in young Italian children referred to the emergency departments for lower respiratory tract infection over two consecutive epidemic seasons.
Rossi GA, Medici MC, Merolla R; Osservatorio VRS Study Group.
Infection. 2005 Feb;33(1):18-24.
The clinical features of respiratory syncytial virus: lower respiratory tract infection after upper respiratory tract infection due to influenza virus.
Nishimura N, Nishio H, Lee MJ, Uemura K.
Pediatr Int. 2005 Aug;47(4):412-6.
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA.
Pediatrics. 1997 Mar;99(3):454-61.
Rehospitalization for respiratory syncytial virus among premature infants.
Joffe S, Escobar GJ, Black SB, Armstrong MA, Lieu TA.
Pediatrics. 1999 Oct;104(4 Pt 1):894-9.
Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR.
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54.
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.
Frogel MP, Stewart DL, Hoopes M, Fernandes AW, Mahadevia PJ.
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. Review.
Respiratory syncytial virus risk factors in late preterm infants.
Lanari M, Silvestri M, Rossi GA.
J Matern Fetal Neonatal Med. 2009;22 Suppl 3:102-7.
Respiratory syncytial virus infection in children hospitalised with acute lower respiratory tract infection.
Hussey GD, Apolles P, Arendse Z, Yeates J, Robertson A, Swingler G, Zar HJ.
S Afr Med J. 2000 May;90(5):509-12.
Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004).
Medici MC, Arcangeletti MC, Rossi GA, Lanari M, Merolla R, Paparatti UD, Chezzi C; Osservatorio VRS Study Group.
New Microbiol. 2006 Jan;29(1):35-43.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on